VirTrial

VirTrial is a technology company that aims to revolutionize the clinical trial industry with its stable telehealth platform. The platform offers a patient management program leveraging video, text, and email to create patient-centric trials, replacing some study visits with virtual ones. The vision is to conduct 25-50% of visits virtually, creating a hybrid model particularly suitable for Phase III and Phase IV trials. This approach allows for remote patient compliance assessment from any location and supports post-approval patient management. The app is compatible with various devices and hosted in a secure, HIPAA-compliant, cloud-based environment.

Founded in 2018, VirTrial operates in the Health and Wellness and Pharmaceutical industries. Through its innovative platform, it aims to enhance trial accessibility for patients, optimize clinical trial site performance, and improve outcomes for pharmaceutical companies. With the potential to hasten the introduction of effective medications to the market, VirTrial presents an intriguing opportunity for venture capital investors.